The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
Open accessAbstract
The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. The full contents can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.13354/full. G protein‐coupled receptors are one of the eight major pharmacological targets into which the Guide is divided, with the others being: G protein‐coupled receptors, ligand‐gated ion channels, voltage‐gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The Concise Guide is published in landscape format in order to facilitate comparison of related targets. It is a condensed version of material contemporary to late 2015, which is presented in greater detail and constantly updated on the website www.guidetopharmacology.org, superseding data presented in the previous Guides to Receptors & Channels and the Concise Guide to PHARMACOLOGY 2013/14. It is produced in conjunction with NC‐IUPHAR and provides the official IUPHAR classification and nomenclature for human drug targets, where appropriate. It consolidates information previously curated and displayed separately in IUPHAR‐DB and GRAC and provides a permanent, citable, point‐in‐time record that will survive database updates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Butters, T. D., van den Broek, L. A. G. M., Fleet, G. W. J., Krülle, T. M., Wormald, M. R., Dwek, R. A., & Platt, F. M. (2000) · Tetrahedron Asymmetry · doi:10.1016/s0957-4166(99)00468-1 · Cited by 147
Bustanji, Y. K., Issa, A., Mohammad, M., Hudaib, M., Tawah, K., AlKhatib, H. S., Almasri, I. M., & Alkhalidi, B. A. (2010) · Journal of Medicinal Plants Research · doi:10.5897/jmpr10.399 · Cited by 124
Laquerre, S. G., Arnone, M. R., Moss, K. G., Yang, J., Fisher, K. E., Kane-Carson, L. S., Smitheman, K. N., Ward, J., Heidrich, B. J., Rheault, T., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.targ-09-b88 · Cited by 55
Cited by
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
Kunnumakkara, A. B., Bordoloi, D., Padmavathi, G., Monisha, J., Roy, N. K., Prasad, S., & Aggarwal, B. B. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13621 · Cited by 1,053
Carotenoids: biochemistry, pharmacology and treatment
Milani, A., Basirnejad, M., Shahbazi, S., & Bolhassani, A. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13625 · Cited by 781
Proanthocyanidins and hydrolysable tannins: occurrence, dietary intake and pharmacological effects
Smeriglio, A., Barreca, D., Bellocco, E., & Trombetta, D. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13630 · Cited by 688
Antioxidant effects of resveratrol in the cardiovascular system
Xia, N., Daiber, A., Förstermann, U., & Li, H. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13492 · Cited by 574
Targeting vascular (endothelial) dysfunction
Daiber, A., Steven, S., Weber, A., Shuvaev, V. V., Muzykantov, V. R., Laher, I., Li, H., Lamas, S., & Münzel, T. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13517 · Cited by 501
The potential health effects of dietary phytoestrogens
Rietjens, I. M. C. M., Louisse, J., & Beekmann, K. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13622 · Cited by 490
Opioids and the immune system – friend or foe
Plein, L. M., & Rittner, H. L. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13750 · Cited by 481
The macrolide antibiotic renaissance
Dinos, G. P. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13936 · Cited by 471
An update on PPAR activation by cannabinoids
O'Sullivan, S. E. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13497 · Cited by 449
Effects of anthocyanins on the prevention and treatment of cancer
Lin, B., Gong, C., Song, H., & Cui, Y. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13627 · Cited by 435
Drug repurposing from the perspective of pharmaceutical companies
Cha, Y., Erez, T., Reynolds, I. J., Kumar, D., Ross, J., Koytiger, G., Kusko, R., Zeskind, B., Risso, S., Kagan, E., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13798 · Cited by 429
Update on melatonin receptors: IUPHAR Review 20
Jockers, R., Delagrange, P., Dubocovich, M. L., Markus, R. P., Renault, N., Tosini, G., Cecon, E., & Zlotos, D. P. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13536 · Cited by 422
Perivascular adipose tissue inflammation in vascular disease
Nosalski, R., & Guzik, T. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13705 · Cited by 398
Shen, C., Jiang, J., Yang, L., Wang, D., & Zhu, W. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13631 · Cited by 344
Reactive oxygen species: key regulators in vascular health and diseases
Chen, Q., Wang, Q., Zhu, J., Xiao, Q., & Zhang, L. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13828 · Cited by 338
Petrosino, S., & Di Marzo, V. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13580 · Cited by 328
Baskaran, P., Krishnan, V., Ren, J., & Thyagarajan, B. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13514 · Cited by 325
Cicero, A. F. G., Fogacci, F., & Colletti, A. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13608 · Cited by 317
Scott, F. L., Clemons, B., Brooks, J., Brahmachary, E., Powell, R., Dedman, H., Desale, H. G., Timony, G. A., Martinborough, E., Rosen, H., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13476 · Cited by 308
The Warburg effect and drug resistance
Bhattacharya, B., Mohd Omar, M. F., & Soong, R. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13422 · Cited by 298
Microtubule destabilising agents: far more than just antimitotic anticancer drugs
Bates, D., & Eastman, A. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13126 · Cited by 298
Melatonin receptors: molecular pharmacology and signalling in the context of system bias
Cecon, E., Oishi, A., & Jockers, R. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13950 · Cited by 281
ROS in gastrointestinal inflammation: Rescue Or Sabotage?
Aviello, G., & Knaus, U. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13428 · Cited by 278
The epigenetic landscape related to reactive oxygen species formation in the cardiovascular system
Kietzmann, T., Petry, A., Shvetsova, A., Gerhold, J. M., & Görlach, A. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13792 · Cited by 253
Dessauer, C. W., Watts, V. J., Ostrom, R. S., Conti, M., Dove, S., & Seifert, R. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013078 · Cited by 201
Haslund‐Vinding, J., McBean, G., Jaquet, V, & Vilhardt, F. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13425 · Cited by 169
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders
Currò, D., Ianiro, G., Pecere, S., Bibbò, S., & Cammarota, G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13632 · Cited by 160
Targeting inflammation to reduce cardiovascular disease risk: A realistic clinical prospect?
Welsh, P., Grassia, G., Botha, S., Sattar, N., & Maffia, P. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13818 · Cited by 164
Therapeutic potential of nadph oxidase 1/4 inhibitors
Teixeira, G., Szyndralewiez, C., Molango, S., Carnesecchi, S., Heitz, F., Wiesel, P., & Wood, J. M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13532 · Cited by 163
Regulation of Wnt/β‐catenin signalling by tankyrase‐dependent poly(ADP‐ribosyl)ation and scaffolding
Mariotti, L., Pollock, K., & Guettler, S. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14038 · Cited by 144
Locci, A., & Pinna, G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13843 · Cited by 132
Machine Learning in Pharmacometrics: Opportunities and Challenges
McComb, M., Bies, R., & Ramanathan, M. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14801 · Cited by 128
Antibiotic-induced dysbiosis of the microbiota impairs gut neuromuscular function in juvenile mice
Caputi, V., Marsilio, I., Filpa, V., Cerantola, S., Orso, G., Bistoletti, M., Paccagnella, N., De Martin, S., Montopoli, M., Dall'Acqua, S., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13965 · Cited by 124
Vascular actions of relaxin: nitric oxide and beyond
Leo, C. H., Jelinic, M., Ng, H. H., Marshall, S. A., Novak, J., Tare, M., Conrad, K. P., & Parry, L. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13614 · Cited by 100
Adrenaline: insights into its metabolic roles in hypoglycaemia and diabetes
Verberne, A. J. M., Korim, W. S., Sabetghadam, A., & Llewellyn‐Smith, I. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13458 · Cited by 99
Mazzanti, G., Moro, P. A., Raschi, E., Da Cas, R., & Menniti‐Ippolito, F. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13171 · Cited by 81
Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes
El Bekay, R., Coín‐Aragüez, L., Fernández‐García, D., Oliva‐Olivera, W., Bernal‐López, R., Clemente‐Postigo, M., Delgado‐Lista, J., Diaz‐Ruiz, A., Guzman‐Ruiz, R., Vázquez‐Martínez, R., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13481 · Cited by 78
Zhang, Y., Shen, X., Xiao, X., Liu, M., Li, S., Yan, J., Jin, J., Gao, J., Zhen, C., Hu, N., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13578 · Cited by 55
Li, L., Sun, H., Ding, J., Niu, C., Su, M., Zhang, L., Li, Y., Wang, C., Gamper, N., Du, X., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14026 · Cited by 51
Yadav, D. B., Maloney, J. A., Wildsmith, K. R., Fuji, R. N., Meilandt, W. J., Solanoy, H., Lu, Y., Peng, K., Wilson, B., Chan, P., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14021 · Cited by 49
Digoxin reduces atherosclerosis in apolipoprotein E‐deficient mice
Shi, H., Mao, X., Zhong, Y., Liu, Y., Zhao, X., Yu, K., Zhu, R., Wei, Y., Zhu, J., Sun, H., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13453 · Cited by 49
Jimenez, M., Gil, V, Martinez‐Cutillas, M., Mañé, N., & Gallego, D. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13918 · Cited by 48
Mahmoudpour, S. H., Baranova, E. V., Souverein, P. C., Asselbergs, F. W., de Boer, A., Maitland‐van der Zee, A. H., & on behalf of the PREDICTION‐ADR consortium (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13090 · Cited by 40
Agarwal, S. R., Miyashiro, K., Latt, H., Ostrom, R. S., & Harvey, R. D. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13904 · Cited by 37
Burston, J. J., Mapp, P. I., Sarmad, S., Barrett, D. A., Niphakis, M. J., Cravatt, B. F., Walsh, D. A., & Chapman, V. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13574 · Cited by 30
Andreetta, F., Carboni, L., Grafton, G., Jeggo, R., Whyment, A. D., van den Top, M., Hoyer, D., Spanswick, D., & Barnes, N. M. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13432 · Cited by 28
Hupp, S., Ribes, S., Seele, J., Bischoff, C., Förtsch, C., Maier, E., Benz, R., Mitchell, T. J., Nau, R., & Iliev, A. I. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14027 · Cited by 12
Metadata
- Authors
- Alexander, S. P., Fabbro, D., Kelly, E., Marrion, N., Peters, J. A., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J. A., & Collaborators, C.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2015-12
- Volume
- 172
- Issue
- 24
- Pages
- 6024-6109
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2196064518
- Cited by
- 604
- References
- 3
- FWCI
- 183.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.